Michael Rowe Email

CEO . Eyenovia

Current Roles

Employees:
90
Revenue:
$18.1M
About
Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.
Eyenovia Address

New York, NY
United States
Eyenovia Email